<?xml version="1.0" encoding="utf-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
>

<channel rdf:about="http://www.cellbiolint.org/">
<title>Cell Biology International Immediate Publications</title>
<link>http://www.cellbiolint.org/</link>
<description>Cell Biology International RSS feed -- Immediate Publications</description>
<prism:issn>1065-6995</prism:issn>
<prism:eIssn>1065-6995</prism:eIssn>
<prism:publicationName>Cell Biology International</prism:publicationName>
<items>
 <rdf:Seq>
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110662" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110653" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20120054" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110687" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100920" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20120060" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110633" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110586" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110404" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110680" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110146" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110591" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110342" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110534" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110542" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20120184" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110348" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110368" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100919" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110628" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110104" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110566" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110602" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110183" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110595" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110111" />
	<!--<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110314" />-->
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100918" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110432" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100649" />
	<rdf:li rdf:resource="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20090021" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.cellbiolint.org/images/cbi_mast_logo2" />
</channel>

<image rdf:about="http://www.cellbiolint.org/images/cbi_mast_logo2">
<title>Cell Biology International</title>
<url>http://www.cellbiolint.org/images/cbi_mast_logo2.gif</url>
<link>http://www.cellbiolint.org/</link>
</image>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110662">
	<title><![CDATA[Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110662</link>
	<description><![CDATA[RNA interference (RNAi) has been widely used to silence specific genes. However, RNAi may also cause off-target silencing and elicit non-specific side effects. To achieve cell-specific gene silencing, a cell-selective promoter has to be used to drive RNAi expression. Furthermore, different terminators of cell-selective promoters may cause different silencing efficacies. In order to explore the best promoter and terminator combination and prove the cell-selective gene silencing effect of prostate-specific membrane antigen (PSMA) promoter (p) and enhancer (e). We first constructed three plasmids by using PSMA e/p and three different terminators (poly(A), minipoly(A), and poly(U)) to explore the cell-selective driving ability of PSMAp/e by targeting EGFP in LNCaP, PC-3, EJ and HEK293 cells. Then we chose nucleostemin (NS), an important endogenous gene of prostate cancer, and constructed the NS-targeting shRNA expression plasmid by using PSMAe/p-poly(A) combination. Cell proliferation, cell cycle and early apoptosis<i> in vitro</i> and xenograft tumor growth in BALB/c nude mice <i>in vivo</i> were detected after NS knockdown. Results showed that PSMAp/e can drive EGFP silencing in LNCaP, not in PC-3, EJ and HEK293 cells and PSMAe/p-poly(A) combination achieved the best silencing efficacy. Then PSMAe/p-shNS-poly(A) drives NS knockdown in LNCaP cells, not in PC-3, EJ and HEK293 cells. Furthermore, RNAi-mediated NS knockdown not only reduces cell proliferation rate, reduces the percentage of S-stage cells and increases the percentage of G1-stage cells and increases the early apoptosis ratio in LNCaP cells <i>in vitro</i>, but also inhibited the LNCaP xenograft tumor growth in BALB/c nude mice <i>in vivo</i> by intratumoral injection. In conclusion, Our study demonstrated that PSMAe/p-poly(A) combination is a promising delivery system for targeted RNAi gene therapy of prostate cancer. We showed one effective antitumor strategy by targeting NS protein, an important target in prostate cancer, with PSMAe/p-shNS-poly(A). These results serve as an important step for developing novel strategies to treat prostate cancer.]]></description>
	<dc:creator>R Liu, J Sun, Z Zhang, Y Xu</dc:creator>
	<dc:date>2012-05-21T13:46:17Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110662</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-21</prism:publicationDate>
	<prism:section>Cancer</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110653">
	<title><![CDATA[Different levels of testicular organization during gonadal differentiation in B6.YTir mice manifesting sex reversal.]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110653</link>
	<description><![CDATA[B6.Y<sup>Tir</sup> mice provide an excellent study model for analyzing the sexual development process that occurs during gonadal differentiation; however the molecular mechanisms which contribute to sexual reversal are not clear. The aim of this study was to establish which molecular events may participate in the sexual reversal of the B6.Y<sup>Tir </sup>mouse. The pattern of gene expression related to testicular (Sry, Sox9 and Mis) and ovarian (Wnt4, Rspo1 and Stra8) differentiation was studied, by applying immunofluorescence and real time RT-PCR and focusing on XY gonads from the B6.Y<sup>Tir</sup> mouse, but also analyzing the normal strains CD-1 and C57/BL6J (B6). It was evident that the expression of genes related to the process of sexual differentiation is altered in the case of the B6.Y<sup>Tir </sup>strain, both at the transcript and protein level inducing differentiation of ovaries and ovotestes; but not the formation of normal testicles. Our results indicated that the expression of testicular genes was inhibited at various levels, permitting the expression of ovarian genes such as Wnt4, Stra8 and Rspo1. However the activity of these genes was not clear when we analyzed our data as an average. Here we present a co-relation analysis indicating that an ovary differentiation pathway is activated, when the testicular differentiation pathway is inhibited.]]></description>
	<dc:creator>N Rocio Antonio-Rubio, N Moreno-Mendoza</dc:creator>
	<dc:date>2012-05-14T14:18:58Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110653</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-14</prism:publicationDate>
	<prism:section>Differentiation</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20120054">
	<title><![CDATA[Sfrp5 expression and secretion in adipocyte are upregulated during the differentiation and are negatively correlated with insulin resistance]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20120054</link>
	<description><![CDATA[This study aimed to examine the patterns of Sfrp5 mRNA expression and protein secretion during the dynamic process of adipocyte differentiation, and investigate the potential role of Sfrp5 in insulin resistance in adipocytes. 3T3-L1 pre-adipocytes were induced for differentiation and RT-PCR and ELISA assays were performed to determine Sfrp5 mRNA expression and protein secretion. The results showed that with the differentiation and maturity of pre-adipocytes, transcription and protein secretion of Sfrp5 gradually increased and peaked on the 9th day of differentiation. Sfrp5 mRNA expression in mature adipocytes was decreased by 20%, 22% and 32% upon treatment with dexamethasone, insulin, and TNF, respectively, while Sfrp5 protein secretion was decreased by 15%, 17% and 30%, correspondingly. In contrast, Sfrp5 mRNA expression in mature adipose was increased by 34% and 19% upon treatment with rosiglitazone and metformin, respectively, while Sfrp5 protein secretion was increased by 10% and 6%, correspondingly. In conclusion, Sfrp5 mRNA expression and protein secretion depend on the differentiation of adipocytes. The dysregulation of Sfrp5 expression and secretion is directly correlated with insulin resistance. Upregulation of Sfrp5 expression and secretion in adipocytes appears to be one crucial mechanism by which rosiglitazone and metformin improve insulin sensitivity.]]></description>
	<dc:creator>C Lv, Y Jiang, H Wang, B Chen</dc:creator>
	<dc:date>2012-05-14T14:16:52Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20120054</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-14</prism:publicationDate>
	<prism:section>Differentiation</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110687">
	<title><![CDATA[Lysophosphatidic acid modulates the association of PTP1B with N-cadherin/catenin complex in SKOV3 ovarian cancer cells]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110687</link>
	<description><![CDATA[Lysophosphatidic acid (LPA) is a natural phospholipid that plays important roles in promoting cancer cell proliferation, invasion, and metastases. We previously reported that LPA induces ovarian cancer cell dispersal and disruption of adherens junction (AJ) through the activation of Src family kinases (SFK). In this study, we aimed to investigate the regulatory mechanisms during the early phase of LPA-induced cell dispersal. We utilize an <i>in vitro</i> model of the ovarian cancer cell line SKOV3 for the cell dispersal study. LPA induces rapid AJ disruption by increasing the internalization of N-cadherin-b-catenin. By using immunoprecipitations, we demonstrate that LPA induces increased tyrosine phosphorylation of b-catenin and alters the balance of b-catenin-bound SFK and phosphotyrosine phosphatase 1B (PTP1B). The altered balance of tyrosine kinase/phosphatase is correlated with a concomitant disintegration of the b-catenin-a-catenin, but not the b-catenin-N-cadherin complex. This disintegration of b-catenin from a-catenin and the cell dispersal caused by LPA can be further rescued by the blockage of SFK activity with the chemical inhibitor PP2. More importantly, PP2 also restores the level of PTP1B bound to b-catenin. We propose that LPA signaling alters AJ stability by changing the dynamics of tyrosine kinase/phosphatase bound to AJ proteins. Our study provides further understanding of the early signaling events regulating ovarian cancer cell dispersal and AJ disruption induced by LPA.]]></description>
	<dc:creator>R Yun-Ju Huang, C Wen, C Liao, S Wang, L Chou, J Wu</dc:creator>
	<dc:date>2012-05-14T14:14:50Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110687</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-14</prism:publicationDate>
	<prism:section>Cancer</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100920">
	<title><![CDATA[Genes Expression Profiling of Peripheral Blood Cells of Patients with Hepatocellular Carcinoma]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100920</link>
	<description><![CDATA[Hepatocellular carcinoma was often diagnosed at advanced stage with poor prognosis. Studies had demonstrated the peripheral blood may be useful for cancer classification. We investigated the peripheral blood genes expression by Affymetrix HG-U133 Plus2.0 microarray in 9 hepatocellular carcinoma patients and 5 healthy normal controls. A total of 726 probe sets showed significant difference based on the criteria of <i>P</i> value &lt; 0.05 and absolute fold change &lt; 2. These genes involved in many kinds of biological functions, including immune response, transcription regulation and metabolism process. 10 genes (IL8, GOS2, CXCR4, FOS, RPS24, HAP90AA1, PFDN5, RPL27, GZMA and PFN1) which showed significant difference were validated by Real-time PCR in 54 hepatocellular carcinoma patients and 56 healthy normal controls. 7 genes (IL8, GOS2, CXCR4, FOS, RPS24, HSP90AA1, PFN1) showed significant difference both Real time PCR and Microarray. The protein expression of IL8 and FOS were up-regulated in hepatocellular carcinoma when compared to the healthy control. We have identified the genes signature in peripheral blood which may classify the hepatocellular carcinoma patients and healthy controls.]]></description>
	<dc:creator>P Zhang, R Wei, X Wen, L Ping, C Wang, Z Dong, X Deng, W Bo, C Bin, Y Tian</dc:creator>
	<dc:date>2012-05-14T13:22:30Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20100920</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-14</prism:publicationDate>
	<prism:section>Cancer</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20120060">
	<title><![CDATA[Epithelial Cells in Culture: Injured or Differentiated Cells ?]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20120060</link>
	<description><![CDATA[Isolation of epithelial cells for cell culture is based on destruction of epithelial integrity. The consequences are manifold: cell polarity and specific cell functions are lost, cells acquire non-epithelial characteristics and start to proliferate. This situation may also occur in situ when parts of the epithelium are lost, either by apoptosis or necrosis by organ or tissue injury. During recovery from this injury, surviving epithelial cells proliferate and may restore epithelial integrity and finally re-differentiate into functional epithelial cells. In vitro, this re-differentiation is mostly not complete due to suboptimal culture conditions. Therefore, cultured epithelial cells resemble wounded or injured epithelia rather than healthy and well differentiated epithelia. The value of an in vitro cell model is the extent to which it helps to understand the function of the cells in situ. A variety of parameters influence the state of differentiation of cultured cells in vitro. Although each of these parameters had been studied, the picture how they coordinately influence the state of differentiation of epithelial cells in vitro is incomplete. Therefore, we discuss the influence of the isolation method and cell culture on epithelial cells, and outline strategies to achieve highly differentiated epithelial cells for the use as an in vitro model.]]></description>
	<dc:creator>P C Baer, J Bereiter-Hahn</dc:creator>
	<dc:date>2012-05-14T13:09:37Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20120060</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-14</prism:publicationDate>
	<prism:section>Differentiation</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110633">
	<title><![CDATA[Replication Mediated Disassociation of Replication protein A-XPA complex upon DNA Damage: Implications for RPA Handing off]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110633</link>
	<description><![CDATA[Replication protein A (RPA), the eukaryotic single-stranded DNA-binding protein, participates in most cellular processes in response to genotoxic insults such as nucleotide excision repair (NER), DNA double-strand break (DSB) repair, and activation of cell cycle checkpoint signaling. RPA interacts with XPA and functions in early stage of NER process. Here we showed that in cells the RPA-XPA complex disassociated upon exposure of cells to high dose of UV irradiation. The disassociation required replication stress and was partially attributed to the RPA hyperphosphorylation. Treatment of cells with camptothecin and hydroxyurea, which cause DSB DNA damage and replication fork collapse, respectively, also led to the disruption of RPA-XPA complex. In addition, purified RPA and XPA were unable to form complex in vitro in the presence of single-stranded DNA. We propose that the competition based RPA switch among different DNA metabolic pathways may regulate the disassociation of RPA with XPA in cells after DNA damage. The biological significances of RPA-XPA complex disruption in relation with checkpoint activation, DSB repair and RPA hyperphosphorylation are discussed.]]></description>
	<dc:creator>G Jiang, Y Zou, X Wu</dc:creator>
	<dc:date>2012-05-11T14:19:18Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110633</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-11</prism:publicationDate>
	<prism:section>Cancer</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110586">
	<title><![CDATA[Nitric Oxide Induces Segregation of Decay Accelerating Factor (DAF or CD55) from the Membrane Lipid-Rafts and its Internalization in Human Endometrial Cells]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110586</link>
	<description><![CDATA[Recent studies suggest that DAF, a complement regulatory protein, present in lipid rafts, is utilized by Dr fimbriated <i>E. coli </i>for their binding and internalization. Previous studies in our laboratory have shown that nitric oxide (NO) can reduce the invasion of Dr (&#x002B;) <i>E. coli</i> and the severity of uterine infection in pregnant rats. Also, the expression level of DAF both at the mRNA and protein levels has been shown to be reduced by NO. Therefore NO mediated down regulation of DAF appears to be an important factor in reducing the susceptibility to <i>E. coli</i> infection. However, it is unclear if NO can actually modulate the membrane association of DAF and therefore initial bacterial binding to cells. Here we show that NO induces the delocalization of DAF from the GM1 rich lipid rafts. Using biochemical and cell biological approaches in a uterine epithelial cell model (Ishikawa cells) we show that upon exposure to NO, DAF accumulates in caveolae. We also show that interaction of DAF with the caveolar protein, caveolin1 leads to their internalization in to endosomes. The NO induced delocalization of DAF from the lipid raft and its accumulation in caveolae are mediated through a cGMP pathway. The acute localized synthesis of NO and its influence on DAF localization may represent an important unrecognized phenomenon of host defense against Dr (&#x002B;) <i>E. coli</i> bacteria, as well as many disease conditions that involve complement system.]]></description>
	<dc:creator>M Banadakoppa, P Goluszko, D Liebenthal, C Yallampalli</dc:creator>
	<dc:date>2012-05-11T11:19:17Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110586</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-11</prism:publicationDate>
	<prism:section>Trafficking</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110404">
	<title><![CDATA[Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110404</link>
	<description><![CDATA[miR-15 and miR-16 are frequently deleted or down-regulated in many cancer cell lines and various tumor tissues, suggesting that miR-15a/16-1 might play important roles in tumor progression and might be a method for cancer treatment. The purpose of this study was to develop a vector-based plasmid to explore the antitumor efficacy of miR-15a/16-1 in colon cancer <i>in vivo</i>. Here, we propose that miR-15a and miR-16-1 may target cyclin B1 (CCNB1) which associates with several tumorigenic features such as survival and proliferation. The levels of miR-15a and miR-16-1 in colon cancer cells are inversely correlated with CCNB1 expression, and we found consensus between miR-15a/16-1 and CCNB1 mRNA sequences by analyzing homology. In the present study, vector-based miR-15a/16-1 expression plasmid was constructed and transfected into HCT 116 and SW620 colon cancer cells <i>in vitro</i>. The negative effects produced on cell viability and angiogenesis were analyzed using flow cytometric analysis, colony formation analysis and tube formation analysis. CCNB1 expression down-regulated was certified by western blotting analysis. Systemic delivery of miR-15a/16-1 plasmids encapsulated in cationic liposome led to a significant inhibition of subcutaneous tumor growth and angiogenesis in tumor tissues, whereas no effects were observed with liposome carrying the non-specific plasmid. Summarily, it&#x2019;s the first time miR-15a/16-1 was applied into colon cancer treatment <i>in vivo</i>, and had resulted in colon tumor xenografts growth arrest and angiogenesis decrease effectively. These findings suggested that systemic delivery of vector-based miR-15a/16-1 expression plasmid might be a potential approach for human colon cancer therapy.]]></description>
	<dc:creator>L Dai, W Wang, S Zhang, Q Jiang, R Wang, L Dai, L Cheng, Y Yang, Y Wei, H Deng</dc:creator>
	<dc:date>2012-05-11T11:09:26Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110404</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-11</prism:publicationDate>
	<prism:section>Cancer</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110680">
	<title><![CDATA[Contribution of Murine Bone Marrow Mesenchymal Stem Cells to Pancreas Regeneration after Partial Pancreatectomy in Mice]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110680</link>
	<description><![CDATA[Recent studies have suggested that the implantation of bone marrow mesenchymal stem cells (BMSCs) has emerged as a potential method of treatment for tissue damage, but the in vivo differentiation of BMSCs in an injured pancreas and its therapeutic effects have not yet been determined. The aim of our studies was to investigate the potential of BMSCs to contribute to the parenchyma and mesenchymal components of the pancreas during rapid regeneration, and we preliminarily explored the molecular mechanisms of this process. In this study, we intravenously infused GFP<sup>&#x002B;</sup> BMSCs into the tail veins of mice that had received a 65%~70% partial pancreatectomy, while mice that had only received a partial pancreatectomy and mice that had only been injected with BMSCs served as controls. Four weeks later, the injected GFP<sup>&#x002B; </sup>BMSCs were diffusely engrafted in the pancreatic parenchyma and mesenchyma of the recipient mice with pancreatic injuries and were differentiated into pancreatic ductal epithelial cells (accounted for 1.7&#x00B1;0.3%), vascular endothelial cells (accounted for 3.2&#x00B1;0.6%) and pancreatic stellate cells (PSCs) (accounted for 5.2&#x00B1;1.6%) but not any pancreatic beta cells or neural cells. Significantly more engrafted and differentiated GFP<sup>&#x002B; </sup>BMSCs were observed in the regenerating pancreas than in the normal pancreas. For the mice that received a partial pancreatectomy, the pancreatic weight/body weight of the mice with BMSC treatment ((0.225&#x00B1;0.042)%) was more than that of the mice without BMSC treatment ((0.183&#x00B1;0.021)%) (p&lt;0.05). In addition, real time RT-PCR showed that the expression levels of miR-9 and miR-204 in the engrafted BMSCs (5.2-fold and 2.6-fold, p&lt;0.05, respectively) were increased compared with wild-type BMSCs. We also observed a significant reduction in the expression of miR-375 (0.71-fold, p&lt;0.05) in engrafted GFP<sup>&#x002B; </sup>BMSCs compared with wild-type BMSCs. Here, we demonstrate that BMSCs can be a potential cell bank for treating pancreatic injuries by contributing to a variety of cell types; this process might be related to the expression of miR-9, miR-204 and miR-375.]]></description>
	<dc:creator>F Han, C Wang, L Yang, S Zhan, M Zhang, K Tian</dc:creator>
	<dc:date>2012-05-11T11:03:26Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110680</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-11</prism:publicationDate>
	<prism:section>Stem cells</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110146">
	<title><![CDATA[Characterization of VAMP-2 in the Lung: Implication in Lung Surfactant Secretion]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110146</link>
	<description><![CDATA[Lung surfactant is crucial for reducing the surface tension of alveolar space, thus preventing the alveoli from collapse. Lung surfactant is synthesized in alveolar epithelial type II cells and stored in lamellar bodies before being released via the fusion of lamellar bodies with the apical plasma membrane. The soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNARE) play an essential role in membrane fusion. We have previously demonstrated the requirement of t-SNARE proteins, syntaxin 2 and SNAP-23, in regulated surfactant secretion. Here, we characterized the distribution of vesicle-associated membrane proteins (VAMPs) in rat lung and alveolar type II cells. VAMP-2, 3 and 8 were shown to be present in type II cells at both mRNA and protein levels. VAMP-2 and -8 were enriched in lamellar body fraction. Immunochemistry studies indicated that VAMP-2 is co-localized with the lamellar body marker protein, LB-180. Functionally, the cytoplasmic domain of VAMP-2, but not VAMP-8 inhibited surfactant secretion in type II cells. This study suggests that VAMP-2 may be the v-SNARE involved in regulated surfactant secretion.]]></description>
	<dc:creator>P Wang, M D. Howard, H Zhang, N Reddy Chintagari, A Bell, N Jin, A Mishra, L Liu</dc:creator>
	<dc:date>2012-05-10T10:48:26Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110146</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-10</prism:publicationDate>
	<prism:section>Exo/endocytosis</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110591">
	<title><![CDATA[Telomerase activity alterations in sequential passages of mouse embryonic stem cells.]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110591</link>
	<description><![CDATA[Telomerase is associated with cell proliferation capacity, protection and stabilization of chromosomes. Telomerase activity (TA) can be detected in highly replicative cells, like stem and cancer cells. Most of available mouse embryonic stem cell (mESC) research worked with few cell lines. The purpose of this study is to evaluate the TA in different passages of newly isolated mESC. TRAP-ELISA method was used in a semi-quantitative evaluation of TA. Three mESC lineages were evaluated (CT2, CT3 and CT4), in three different passages (P13, P15 and P19). Differently of previous studies, the mESC lines studied did not show the same TA throughout the passages, showing initial low TA values, followed by a subsequent rise and then stabilization.]]></description>
	<dc:creator>F de Assis Nunes Pereira, R L Tavares, A Fernando Camargos, A Lopes da Silva-Filho</dc:creator>
	<dc:date>2012-05-04T13:13:05Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110591</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-04</prism:publicationDate>
	<prism:section>Stem cells</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110342">
	<title><![CDATA[A Column based rapid method for the simultaneous isolation of DNA, RNA, miRNA and proteins]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110342</link>
	<description><![CDATA[In the 21<sup>st</sup> century, emerging area of systems biology is a whole-istic approach to understand biology by the crosstalk study between genome, Rnome and proteome of a cell. Here we describe a column based rapid method for the simultaneous extraction of nucleic acids, small RNAs and proteins from the same experimental sample (without fractionation) allowing for direct correlations between genomic, epi-genomic, transcriptomic and proteomic data, thus reducing inconsistent results and variability. Our method provides a rapid isolation of crucial biomolecules within one hour with the highest quality of isolated biomolecules. Further isolated DNA, RNA and miRNAs are suitable for all common downstream applications such as PCR, RT-PCR, reverse Northern blotting and Real time PCR. Similarly isolated protein is also suitable for SDS-PAGE and Western blot analysis. The buffers and reagents used in this method are optimized extensively to achieve the cost effective and reliable procedure to separate the functional biomolecules of the cell.]]></description>
	<dc:creator>S K Rajput, V P Dave, A Rajput, H P Pandey, T K Datta, R K Singh</dc:creator>
	<dc:date>2012-05-03T13:37:54Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110342</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-03</prism:publicationDate>
	<prism:section>Trafficking</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110534">
	<title><![CDATA[Overexpression of phosphatase regenerating liver 3 in esophageal squamous cell carcinoma associated with metastasis and its comparison with phosphatase regenerating liver 1]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110534</link>
	<description><![CDATA[Expression of PRL 3 protein was examined with immunohistochemistry in 60 cases of esophageal squamous cell carcinoma (ESCC) with matched lymph node metastasis (N=40) and 6 cases of esophageal adenocarcinoma. Its associations with PRL1 and clinicopathological parameters were analyzed. The results showed the frequency of PRL 3 protein expression, like PRL1, was significantly higher in ESCC (39/60, 65%) than in normal esophageal mucosa (0/20, p&lt;0.001); higher in ESCC with lymph node metastasis (30/40, 75%) than in ESCC without lymph node metastasis (9/20, p=0.022), as well as higher in metastatic ESCC in lymph node (38/40, 95%) than in the primary ESCC (39/60, 65%, p&lt;0.001). PRL3 was expressed in 1 out of 6 esophageal adenocarcinomas but did not exhibit any nuclear staining of PRL1. Expression of PRL-3 protein was positively associated with the grade and partially with the stage of ESCC. These results suggest that expression of PRL-3 protein may be involved in the metastasis of ESCC and serve as a biomarker for prediction of ESCC metastasis.]]></description>
	<dc:creator>X Lou, Y Liu, K Guo, J Lei, H Li</dc:creator>
	<dc:date>2012-05-03T10:01:10Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110534</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-03</prism:publicationDate>
	<prism:section>Cancer</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110542">
	<title><![CDATA[Retinoic acid promotes proliferation of chicken primordial germ cells via activation of PI3K/Akt-mediated NF-{kappa}B signaling cascade]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110542</link>
	<description><![CDATA[As embryonic progenitors for the gametes, primordial germ cells (PGCs) proliferate and develop under strict regulation of numerous intrinsic and external factors. As the most active natural metabolite of vitamin A, all-trans retinoic acid (RA) performs pivotal roles in regulating development of various cells. In this study, the proliferating effect of RA on PGCs was investigated along with the intracellular PI3K/Akt-mediated NF-&#x03BA;B signaling cascade. Results showed that RA significantly promoted PGC proliferation in a dose- and time-dependent manner, which was confirmed by BrdU incorporation and cell cycle analysis. However, this promoting effect was attenuated obviously by sequential inhibitors of LY294002 for PI3K, KP372-1 for Akt and SN50 for NF-&#x03BA;B, respectively. Furthermore, Western blot analysis manifested increased Akt phosphorylation (Ser<sup>473</sup>) of PGCs after stimulation with RA, but this effect was abolished by LY294002 or KP372-1. Meanwhile, treatment with RA increased expression of NF-&#x03BA;B and decreased I&#x03BA;B&#x03B1; expression that were inhibited by SN50. Moreover, blockade of PI3K or Akt activity resulted in inhibiting NF-&#x03BA;B translocation from the cytoplasm to the nucleus. Finally, the up-regulated mRNA expression of cell cycle regulating genes (cyclin D1 and E, cyclin-dependent kinases 6 and 2) was observed in the RA-treated cells. Again, this stimulation was remarkably retarded by combined treatment with LY294002, KP372-1 and SN50, respectively. Therefore, these results suggest that the vitamin A metabolite RA activates the PI3K/Akt and NF-&#x03BA;B signaling cascade to promote proliferation of the cultured chicken PGCs.]]></description>
	<dc:creator>M Yu, C Ge, W Zeng, Y Mi, C Zhang</dc:creator>
	<dc:date>2012-05-02T09:57:43Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110542</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-05-02</prism:publicationDate>
	<prism:section>Signalling</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20120184">
	<title><![CDATA[Mechanotransduction and Focal Adhesions]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20120184</link>
	<description><![CDATA[Cellular focal adhesions respond to internal and external mechanical stresses, making them prime candidates for mechanotransduction. Recent observations have shown that the focal adhesion proteins, including vinculin, focal adhesion kinase (FAK), and p130Cas, are crucial for the ability of cells to transmit forces and generate cytoskeletal tension. When mechanically stimulated, cells respond by modulating the spreading area, remodel their actin cytoskeleton, activate actomyosin interactions, recruit integrins, and reinforce focal adhesions and cytoskeletal structures. These complex cellular responses are orchestrated such that mechanical stresses within the focal adhesion complex remained within a narrow range.]]></description>
	<dc:creator>W H Goldmann</dc:creator>
	<dc:date>2012-04-24T11:10:11Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20120184</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-24</prism:publicationDate>
	<prism:section>Cytoskeleton</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110348">
	<title><![CDATA[Expression of the poly alanine expansion mutatant of nuclear Poly (A) binding protein induces apoptosis via the p53 pathway]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110348</link>
	<description><![CDATA[The nuclear poly (A) binding protein (PABPN1) is ubiquitous and binds to the nascent mRNA transcript and controls the poly (A) tract elongation process in multicellular organisms. Expansion of GCG repeats which encode first six of the ten alanines of a poly alanine tract at the N-terminus of wild type PABPN1 to 12-17 alanines cause aggregation of the protein and cell death. Patients with the adult onset autosomal dominant oculopharyngeal muscular dystrophy (OPMD) carry the GCG expansion mutation in their PABPN1 gene. The symptoms of OPMD include drooping eye lids and swallowing difficulty. The severity of symptoms increases with the length of the expansion. In this study we have investigated the mechanism of cell death in HeLa and HEK293 cultured cells expressing the mutant PABPN1 with a poly alanine tract containing 17 alanines (PABPN1-A17). Our results show that in cells expressing PABPN1-A17, the abundance of pro&#x2013;apoptotic proteins p53, Puma and Noxa are upregulated. This was associated with the redistribution of p53 to the nucleus and mitochondria. Concomitantly Bax was translocated to the mitochondria and was followed by the release of cytochrome c and the cleavage of caspase 3. Furthermore, blocking p53 mediated transcription using Pifithrin significantly reduced apoptosis in these cells. Our findings, therefore, suggest a key role of p53 mediated apoptosis in death of cells expressing the poly alanine expansion mutant of PABPN1.]]></description>
	<dc:creator>R Biswas Bhattacharjee, T Zannat, J Bag</dc:creator>
	<dc:date>2012-04-23T10:34:35Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110348</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-23</prism:publicationDate>
	<prism:section>Cell death</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110368">
	<title><![CDATA[EBV upregulates cytochrome C through VDAC1 regulations and decreases the release of cytoplasmic Ca2{+} in the NPC cell line]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110368</link>
	<description><![CDATA[Epstein-Barr virus (EBV) was considered as a major factor that causes nasopharyngeal carcinoma (NPC), which is one of the sneakiest cancers frequently occurred in Southeast Asia and southern China Apoptosis and pro-apoptotic signals have been studies for decades. However, few researches have extended the prevailing view of EBV to its impact on NPC in perspective of apoptosis. One of the important proteins named voltage dependent anion-selective protein 1 (VDAC1) on the mitochondrial out membrane controlls the pro-apoptotic signals in mammalian cells. The impact of EBV infection towards VDAC1 and related apoptotic signals remains unclear. In order to study the VDAC1&#x2019;s role in EBV infected NPC cells, we employ siRNA inhibition to analyze the release of Ca<sup>2&#x002B;</sup> and Cytochrome C signals in the cytoplasm, as they are important pro-apoptotic signals. The results shows decrease of Ca<sup>2&#x002B;</sup> release and up-regulation of Cytochrome C (Cyto C) upon EBV infection. After siRNA transfection, the dysregulatoin of Cyto C was neutralized, which gives the evidence that the level of Cyto C&#x2019;s release in virus infected NPC cells was as same as that of non-infected NPC cells. This result indicates that EBV infection changes the cytoplasmic level of Cyto C through regulating VDAC1. In summary, this study firstly reports EBV can change the release of Ca<sup>2&#x002B;</sup> and Cyto C in the cytoplasm of NPC cells and these changes were mediated by VDAC1 regulation.]]></description>
	<dc:creator>X Feng, C Ching, W Chen</dc:creator>
	<dc:date>2012-04-13T11:33:05Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110368</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-13</prism:publicationDate>
	<prism:section>Cell death</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100919">
	<title><![CDATA[Na{+}/H{+} exchanger 1 inhibition contributes to K562 leukemic cell differentiation]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100919</link>
	<description><![CDATA[We studied the effect of hypoxia on the differentiation of chronic myeloid leukemic K562 cells, and characterized the role of Na<sup>&#x002B;</sup>/H<sup>&#x002B;</sup> exchanger 1 (NHE1) in this process. The K562 cells were tested for differentiation-related morphological characterization using light microscopy. The fluorescent probe BCECF was used for intracellular pH (pH<sub>i</sub>) measurements. Expressions of NHE1 and differentiation-related genes were analyzed by real-time RT-PCR. The cytokine release was determined by protein microarray assay. Signaling pathways were examined by western blotting using phosphospecific antibodies. As a result, hypoxia induced the differentiation of K562 cells as evidenced in the modifications in morphological features, up-regulation of CCAAT/enhancer-binding protein &#x03B1; (C/EBP&#x03B1;), and marked IL-8 release. Inhibition of NHE1 under hypoxia additionally enhanced the levels of C/EBP&#x03B1; and further promoted leukemia cells differentiation. Furthermore, the pharmacological inhibition of p38 mitogen-activated protein kinase (p38 MAPK) significantly suppressed C/EBP&#x03B1; expression under hypoxia conditions after NHE1 inhibition. These results indicate the enhancement of hypoxia-induced K562 differentiation by NHE1 inhibition which may be through the up-regulation of C/EBP&#x03B1; via p38 MAPK signaling pathway, and suggest a possible therapeutic target of NHE1 under hypoxia microenvironment in the treatment of leukemic diseases.]]></description>
	<dc:creator>W Jin, Q Li, J Wang, G Chang, Y Lin, H Li, L Wang, W Gao, T Pang</dc:creator>
	<dc:date>2012-04-12T11:01:46Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20100919</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-12</prism:publicationDate>
	<prism:section>Differentiation</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110628">
	<title><![CDATA[Overexpression of the gap junction protein Cx43 as found in diabetic foot ulcers can retard fibroblast migration]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110628</link>
	<description><![CDATA[Poor healing of diabetic foot ulcers is a major clinical problem that can be extremely debilitating and lead to lower limb amputation. In the normal acute wound, the Connexin 43 gap junction protein is down-regulated at the wound edge as a precursor to cell migration and healing. In fibroblasts from the human chronic diabetic foot ulcer wound edge there was a striking and significant 10-fold elevation of Connexin 43 protein, as well as a 6-fold increase in N-cadherin and a 2-fold increase in Zonular Occludin-1, as compared to unwounded skin. In streptozotocin diabetic rats Connexin 43 was found to be upregulated in intact dermal fibroblasts in direct proportion to blood glucose levels and increased 2-fold further in response to wounding of the skin. To mimic diabetes, 3T3 fibroblasts were cultured under different concentrations of glucose or mannitol and Connexin 43 protein intercellular communication and migration rates were determined. Cultures of fibroblasts in very high (40mM) glucose conditions showed significantly elevated Connexin 43 protein levels, as shown by immunostaining and Western Blot, and significantly increasing gap junctional communication, as shown by dye transfer. In scratch wound healing assays, increased levels of Connexin 43 from high glucose resulted in repressed filopodial extensions and significantly slower migration rates than in either standard conditions (5.5mM glucose) or the osmotic control of mannitol. Conversely, when glucose-induced Connexin 43 upregulation was prevented with Connexin43shRNA transduction, the fibroblasts extended long filopodia and migrated significantly faster. Connexin 43 protein was upregulated in fibroblasts in diabetic foot ulcers as well as after high glucose exposure in culture which correlated with inhibition of fibroblast migration and is likely to contribute to impaired wound healing.]]></description>
	<dc:creator>A Mendoza-Naranjo, P Cormie, A E Serrano, C M Wang, C Thrasivoulou, J ES Sutcliffe, D J Gilmartin, J Tsui, T E Serena, A RJ Phillips, D L Becker</dc:creator>
	<dc:date>2012-03-28T15:32:44Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110628</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-03-28</prism:publicationDate>
	<prism:section>Signalling</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110104">
	<title><![CDATA[Characterization of transcriptional profiling of Kupffer cells during liver regeneration in rats]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110104</link>
	<description><![CDATA[<b>Abstract
</b>Kupffer cells (KCs), as an important hepatic immunoregulatory cells, play a key role in liver regeneration (LR). Uncovering the transcriptional profiling of KCs after partial hepatectomy (PH) would likely clarify its implication in LR. Here, we isolated KCs by methods of Percoll density gradient centrifugation and immunomagnetic beads. Transcriptional profiles of KCs were monitored up to 168h post-PH using microarray. By comparing the expression pro&#xFB01;le of KCs at 2-168 h post-PH with that of the control and applying tbe statistical and bioinformatics criteria, we found 1407 known and 927 unknown genes related to LR. K-means clustering analysis grouped these 1407 genes into robust fourteen time-course clusters representing distinct patterns of regulation. Based on gene set enrichment analysis, genes encoding products involved in cytokine signaling, inflammatory response and cell chemotaxis were highly enriched in the cluster characterized by gradual upregulation and then return; genes in defense response and immune response were enriched in clusters &#x201C;the general down-regulation during LR&#x201D;; genes in fatty acid synthesis and sterol metabolism were preferentially distributed in the cluster &#x201C;gradual increase&#x201D;; while genes in the categories &#x201C;lipid catabolism&#x201D; and &#x201C;glycolysis&#x201D; were enriched in cluster &#x201C;decrease at two intervals&#x201D;. According to above analysis, KCs were seemingly sensitive to operative stimulus; immune defense and detoxification function of KCs obviously dropped postoperatively; fatty acid synthesis were enhanced, while lipid catabolism and glycolysis were reduced after PH. This study provides a detailed in vivo gene expression pro&#xFB01;le of Kupffer cells, providing a framework to better understand the molecular mechanisms underlying the regeneration process at cellular level.]]></description>
	<dc:creator>C Xu, X Chen, C Chang, G Wang, W Wang, L Zhang, Q Zhu, L Wang</dc:creator>
	<dc:date>2012-03-27T14:43:06Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110104</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-03-27</prism:publicationDate>
	<prism:section>Division</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110566">
	<title><![CDATA[The protection of cells from nitric oxide-mediated apoptotic death by glutathione C60 derivative]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110566</link>
	<description><![CDATA[The influence of glutathione C<sub>60</sub> derivative on the cytotoxicity of a highly reactive free radical nitric oxide (NO) was investigated. Consistent with its cytoprotective abilities, the derivative can scavenge the reactive oxygen species and reactive nitrogen species both in vitro and in cell free condition. Moreover, glutathione C<sub>60</sub> derivative protected PC12 cells from the cytotoxic effect of NO-releasing compounds sodium nitroprusside. Experiments also demonstrated that addition of glutathione C<sub>60</sub> derivative alone didn&#x2019;t induce apoptosis and necrosis. The results suggest that glutathione C<sub>60</sub> derivative have the potential to prevent NO-mediated cell death without evident toxicity.]]></description>
	<dc:creator>Z Hu, C Zhang, P Tang, C Li, Y Yao, S Sun, L Zhang, Y Huang</dc:creator>
	<dc:date>2012-03-22T15:34:02Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110566</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-03-22</prism:publicationDate>
	<prism:section>Cell death</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110602">
	<title><![CDATA[Can mesenchymal stem cells prevent Parkinson{'}s Disease in at-risk individuals? Protecting dopaminergic neurons in the substantia nigra from oxidative insult]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110602</link>
	<description><![CDATA[Parkinson&#x2019;s Disease (PD) is characterized by the selective loss of dopaminergic neurons in the <i>substantia nigra</i> of the midbrain region, but not in the ventral tegmental area and other catecholaminergic cell group areas. The etiology of PD is attributed both to environmental and genetic causes, and certain population of individuals may be classified as at-risk of developing PD later in life. However, there are as yet no therapy regimens that can help to delay or prevent the onset of the disease to realize long-term benefits from this early diagnosis. In PD, a vicious cycle gets initiated in the <i>substantia nigra</i>, due to which susceptible neurons continue to degenerate while damaged neurons do not get enough support for regeneration. This happens primarily due to the local environment of oxidative damage brought about by the dual presence of dopamine and high levels of iron, decline in cellular detoxification systems and low density of glial cells surrounding the dopaminergic neurons in the mesencephalic region. To enhance the defense mechanism of the <i>substantia nigra</i> in this situation, it is necessary to combat the oxidative insult while providing trophic factors for the survival and regeneration of the damaged neurons. In light of <i>in vitro</i> and <i>in vivo</i> studies, mesenchymal stem cells (MSCs) as candidates for cell-based therapies in PD have greater scope than as mere replacement of cell type, since they can be used as a cellular system for the detoxification of ROS as well as a supplier of neurotrophic factors to modulate the local environment. Building on progress in unraveling the multipronged effect of MSCs, we therefore hypothesize that MSCs could be used as a prophylactic strategy to delay or prevent the onset of PD in at-risk individuals, and to slow down the progression of the disease.]]></description>
	<dc:creator>I Datta, R Bhonde</dc:creator>
	<dc:date>2012-03-14T16:51:30Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110602</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-03-14</prism:publicationDate>
	<prism:section>Stem cells</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110183">
	<title><![CDATA[BONE MARROW DERIVED MESENCHYMAL STEM CELLS FROM AGED MICE HAVE REDUCED WOUND HEALING, ANGIOGENESIS, PROLIFERATION AND ANTI-APOPTOSIS CAPABILITIES]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110183</link>
	<description><![CDATA[Old age is a major risk factor for many diseases and disorders. Decline in the function of stem cells like other cells of the body with age results in an imbalance between cell loss and cell renewal. The increasing age of the donor thus diminishes the effectiveness of MSCs transplantation for age related diseases. The clinical use of stem cell therapies needs autologous stem cell transplantation therefore it is essential to study the repair ability and survivability of cells before transplantation. Bone marrow derived mesenchymal stem cells possess multi-lineage differentiation potential but aging has adverse effect on their therapeutic efficacy. In the present study, MSCs from young (2-3 months) and aged (23-24 months) GFP expressing C57BL/6 mice were isolated and their regenerative potential was evaluated in-vitro. Real time RT-PCR revealed significantly higher expression of Sirt1 in MSCs isolated from young than aged animals. Down-regulation of VEGF, SDF-1, AKT and up-regulation of p53, p21, Bax and p16 was observed in aged cells. The tube formation, wound healing and proliferative abilities of young MSCs were better than aged MSCs. The results of present study suggest that age related increased expression of apoptotic and senescent genes with concomitant decrease in Sirt1 gene expression may play an inhibitory role on stem cell functionality.]]></description>
	<dc:creator>M Saba Choudhery, M Khan, R Mahmood, A Mehmood, S N Khan, S Riazuddin</dc:creator>
	<dc:date>2012-02-22T10:54:14Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110183</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-02-22</prism:publicationDate>
	<prism:section>Stem cells</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110595">
	<title><![CDATA[Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells (hUCB-MSC) Inhibits the Proliferation of K562 (Human Erythromyeloblastoid Leukemic Cell Line)]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110595</link>
	<description><![CDATA[Human umbilical cord blood derived-mesenchymal stem cells (hUCB-MSC) offers an attractive alternative to bone marrow-derived MSC for cell-based therapy as it is a less invasive source of biological material. However, limited studies have been conducted with hUCB-MSC as compared to bone marrow-derived MSC. The objectives of this study are to evaluate the effect of hUCB-MSC on the proliferation of K562 (a erthryomyeloblastoid cell line) and the cytokine secretion pattern of hUCB-MSC. Co-culturing of hUCB-MSC and K562 resulted in inhibition of proliferation of K562 in a dose-dependent manner. However, the anti-proliferative effect was reduced as demonstrated by the transwell system suggesting the importance of direct cell-to-cell contact. hUCB-MSC inhibited proliferation of K562 by arresting them in the G<sub>0</sub>/G<sub>1</sub> phase of the cell cycle. Nitric oxide (NO) was not involved in the hUCB-MSC-mediated tumor suppression. The presence of IL-6 and IL-8 were obvious in the hUCB-MSC conditioned media. No significant increase in 29 other cytokines including chemokines, epidermal growth factor, vascular endothelial growth factor (an angiogenic growth factor), TNFR1, TNFRII, adhesion molecules ICAM-1, VCAM-1 and metalloproteinase MMP3 was detected. This is the first report to show that Th1 cytokines, IFN-&#x03B3;, Th2 cytokine IL-4 and Th17 cytokine, IL-17 were not secreted by hUCB-MSC. hUCB-MSC cocultured with K562 showed an increased number of hUCB-MSC expressing latent membrane-bound form of TGF-&#x03B2;1. The present study indicated that the antiproliferative effect of hUCB-MSC on K562 was due to arrest of the growth of K562 in the G<sub>0</sub>/G<sub>1</sub> phase of the cell cycle. The mechanisms underlying the increased IL-6 and IL-8 secretion and LAP(TGF- &#x03B2;1) by hUCB-MSC remains to be investigated.]]></description>
	<dc:creator>M Fonseka, R Ramasamy, W Kien Yip, B Chong Tan, H Fong Seow</dc:creator>
	<dc:date>2012-02-16T12:32:12Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110595</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-02-16</prism:publicationDate>
	<prism:section>Stem cells</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110111">
	<title><![CDATA[Extracellular Nucleotide Inhibits Cell Proliferation and Negatively Regulates Toll-like Receptor 4 Signaling in Human Progenitor Endothelial Cells]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110111</link>
	<description><![CDATA[Extracellular nucleotides mediate a wide range of physiological effects by interacting with plasma membrane P2 purinergic receptors. Recently, it had been reported that P2 receptors are expressed in certain kinds of stem cells, and function to induce cytokine expression and to modulate cell proliferation. In the present study, we analyzed the expression and the function of P2 receptors in human umbilical cord blood-derived EPCs. We demonstrated here that EPCs expressed P2X4,6,7 and P2Y2,4,11,13,14 receptors and extracellular ATP inhibited EPCs proliferation. In accord with our previous study, we found that EPCs expressed functional TLR4 and the activation of TLR4 by LPS evoked a proinflammatory immune response. When human EPCs were stimulated with LPS and nucleotides, we found that ATP or UTP inhibited the expression of proinflammatory cytokines including MCP-1, IFN-&#x03B1;, TNF-&#x03B1; and adhesion molecule VCAM-1 induced by LPS. Furthermore, ATP and UTP down-regulated the gene expression of TLR4, CD14 and myeloid differentiation factor 88 (MyD88), a TLR adaptor molecule, and protein expression of CD14 and MyD88. Moreover, the phosphorylation of NF-&#x03BA;B p65 induced by TLR4 activation was inhibited partly by ATP or UTP at concentrations of 1~5 &#x00B5;M. These results suggested that extracellular nucleotides negatively regulated EPCs proliferation and TLR4 signaling.]]></description>
	<dc:creator>Z Xiao, M Yang, F Li, Q Lv, Q He, M Deng, X Liu, X Chen, M Chen, X Xie, J Hu</dc:creator>
	<dc:date>2012-02-02T15:09:56Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110111</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-02-02</prism:publicationDate>
	<prism:section>Stem cells</prism:section>
</item>

<!--
<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110314">
	<title><![CDATA[Epigenetic control of TNAP expression in Pseudoxanthoma elasticum fibroblasts]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110314</link>
	<description><![CDATA[Progressive calcification and fragmentation of elastic fibers are characteristic hallmarks of Pseudoxanthoma elasticum (PXE) which is caused by mutations in the ABCC6 gene encoding the multidrug resistance-associated protein 6 (MRP6). Several evidences suggested that PXE is a metabolic disorder but the exact mechanism by which ABCC6 mutations promote the elastic fiber mineralization is unknown. To shed light in this issue, we analyzed, by real-time PCR, the expression profile of a number of genes involved in matrix gla-protein (MGP) &#x03B3;-carboxylation and in phosphate generation, in healthy and PXE dermal fibroblasts. Tissue nonspecific alkaline phosphatase (TNAP), NADPH: P450 reductase (P450R) and Protein Disulphyde Isomerase (PDIA2) mRNAs showed meaningfull quantitative differences in PXE fibroblasts with respect to the control cells. In order to verify whether epigenetic events can regulate the expression of genes involved in the PXE phenotype, we investigated DNA methylation and hystone acetylation status of TNAP and PDIA2. Our results demonstrate that in vivo methylation of TNAP promoter is inversely correlated with the gene expression level. Moreover, TNAP expression in PXE fibroblasts is susceptible to the methylation status of promoter, while, in healthy fibroblasts, some other control mechanism prevails.]]></description>
	<dc:creator>A Ostuni, V Infantino, A Salvia, R Miglionico, F Boraldi, G Annovi, F Bisaccia</dc:creator>
	<dc:date>2012-01-26T14:15:52Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110314</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-01-26</prism:publicationDate>
	<prism:section>Signalling</prism:section>
</item>
-->

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100918">
	<title><![CDATA[Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100918</link>
	<description><![CDATA[Substantial data indicate that the oncogene microRNA-155 is significantly elevated in glioblastoma multiforme (GBM) and regulates multiple genes associated with cancer cell proliferation, apoptosis, and invasiveness. Thus, miR-155 can theoretically become a target to enhance the chemotherapeutic effect in cancer therapy. So far, the effect of down-regulating miR-155 to enhance the chemotherapeutic effect to taxol has not been studied in human GBM. Human GBM U251 cell were treated with taxol and the miR-155 inhibitor, alone or in combination. The 50% inhibitory concentration and cell viability were determined by the MTT assay. Annexin V/PI staining was performed, and apoptosis and the cell cycle were evaluated by flow cytometry analysis. Expression of miR-155 was real-time PCR and western blotting was performed to evaluate malignancy related protein alteration. IC<sub>50</sub> values were dramatically decreased in cells treated with miR-155 inhibitor combine with taxol, to a greater extent than those treated with taxol alone. Furthermore, the miR-155 inhibitor significantly enhaced apoptosis in U251 cell. Interestingly, the above data suggested that in GBM cells, miR-155 blockage increased the chemosensitivity to taxol. The data strongly suggested that a regulatory loop between miR-155 might provide an insight into the mechanism of modulating EAG1 signaling. Taken together, the miR-155 inhibitor could enhance the chemosensitivity of human glioblastoma cells to taxol. A combination of miR-155 inhibitor and taxol could be an effective therapeutic strategy for controlling the growth of GBM by inhibiting EAG1 expression.]]></description>
	<dc:creator>w meng, L Jiang, L lu, H Hu, H Yu, D Ding, K Xiao, W Zheng, H Guo, W Ma</dc:creator>
	<dc:date>2012-01-26T12:01:06Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20100918</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-01-26</prism:publicationDate>
	<prism:section>Cancer</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110432">
	<title><![CDATA[Inhibition of acid-sensing ion channels by amiloride protects rat articular chondrocytes from acid-induced apoptosis via a mitochondrial-mediated pathway]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20110432</link>
	<description><![CDATA[A signi&#xFB01;cant decrease in tissue pH or acidosis is a common feature of numerous diseases, including rheumatoid arthritis (RA). Cartilage homeostasis is profoundly affected by local acidosis in the joints. The diuretic, amiloride, has recently been shown to be neuroprotective in models of cerebral ischemia, a property attributable to the inhibition of acid-sensing ion channels (ASICs) by the drug. However, little known about the effect of amiloride on apoptosis induced by extracellular acid in articular chondrocytes. In this study, we found that amiloride could restrain the acid-induced apoptosis of rat articular chondrocytes in vitro. Primary rat articular chondrocytes were isolated, cultured, and induced to apoptosis by exposure to extracellular solution (pH 6.0),while simultaneously treated with various concentrations of amiloride (50, 100, or 200 &#x03BC;M).The apoptotic rate, mitochondrial function, levels of apoptosis-related gene Bcl-2 family mRNA and activity of caspase-3/9 in chondrocytes were examined. The results showed that amiloride inhibited chondrocyte apoptosis in a dose-dependent manner. Furthermore, amiloride partly restored the levels of mitochondrial membrane potential by regulation of Bcl-2 family gene mRNA expression, and activity of caspase-3/9 in chondrocytes induced by extracellular acid. Our results indicated that amiloride protected against acid-induced apoptosis in rat articular chondrocytes by increasing anti-apoptotic ability and down-regulation of pro-apoptotic factors, thus protecting mitochondrial function.]]></description>
	<dc:creator>C Rong, F Chen, S Jiang, W Hu, F Wu, T Chen, F Yuan</dc:creator>
	<dc:date>2011-12-15T11:15:00Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20110432</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2011-12-15</prism:publicationDate>
	<prism:section>Cell death</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100649">
	<title><![CDATA[Humanised substitutes for animal sera in human mesenchymal stem cell culture and differentiation]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20100649</link>
	<description><![CDATA[The use of animal sera in cell culture is a major deterrent for using such cells in cellular therapy owing to potential contamination with xenogenic agents. This necessitates the development of &#x2018;humanized&#x2019; supplements to overcome such problems. This study investigates the use of two &#x2018;human-derived&#x2019; supplements, namely human platelet lysate (hPL) and umbilical cord blood serum (UCBS), in human mesenchymal stem cell (hMSCs) culture. Properties of hMSCs cultured in either of these supplements including growth kinetics and the differentiation potential were better than those cultured in animal sera-supplemented media. This is also the first report concerning hepatogenic differentiation of hMSCs cultured in UCBS-supplemented media. Development of &#x2018;humanized&#x2019; alternatives to FBS could be revolutionary in terms of extrapolating results from in-vitro cultured / expanded hMSCs to direct clinical cellular therapeutic strategies.]]></description>
	<dc:creator>K Sankaranarayanan, C T., G Ponrose G., M V., P U., C Maria Renny, U Raghavan, S R., S Guhathakurta, C K. M.</dc:creator>
	<dc:date>2011-04-15T09:27:47Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20100649</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2011-04-15</prism:publicationDate>
	<prism:section>Stem cells</prism:section>
</item>

<item rdf:about="http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20090021">
	<title><![CDATA[Controlling the in vitro differentiation of embryonic stem cells for myocardial tissue engineering applications]]></title>
	<link>http://www.cellbiolint.org/cbi/imps/refer.htm?MSID=CBI20090021</link>
	<description><![CDATA[We studied the differentiation of embryonic stem cells (ESCs) and developed a novel protocol for generating functional cardiomyocytes (CMs) from ESCs by co-culturing these with live cardiac cells. We then evaluated the structural and functional properties of these ESC-derived CMs (ESCMs). An acellular matrix obtained from rabbit heart tissues was used as a scaffold. Then ESCMs were seeded onto the acellular matrix for preliminary tissue engineering applications. We found that by mimicking the cardiac microenvironment, the percentage of beating embryoid bodies (EBs) was much higher and the homogeneity of EBs were significantly improved over that seen in the control group (p&lt;0.001). ESCMs in EBs acquired almost the same structural and functional properties as typical CMs. After implantation, the cells in the EBs rapidly grew and expanded in the extracellular matrix. These results indicate that the differentiation of ESCs can be controlled in a cardiac mimicking microenvironment and that ESCs can be used as an ideal cell source for large-scale tissue engineering applications for the procurement of cardiac muscle.]]></description>
	<dc:creator>D Ou, R Chen, X Liu, J Guo, H Wang, Q Zheng</dc:creator>
	<dc:date>2009-09-15T15:09:57Z</dc:date>
	<dc:identifier>doi:10.1042/CBI20090021</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2009-09-15</prism:publicationDate>
	<prism:section>Stem cells</prism:section>
</item>


</rdf:RDF>

